TCL Archive Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds October 31, 2003
TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014